Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axogen (AXGN) Common Equity (2016 - 2025)

Axogen (AXGN) has 16 years of Common Equity data on record, last reported at $128.8 million in Q4 2025.

  • For Q4 2025, Common Equity rose 24.0% year-over-year to $128.8 million; the TTM value through Dec 2025 reached $128.8 million, up 24.0%, while the annual FY2025 figure was $128.8 million, 24.0% up from the prior year.
  • Common Equity reached $128.8 million in Q4 2025 per AXGN's latest filing, up from $120.8 million in the prior quarter.
  • Across five years, Common Equity topped out at $128.8 million in Q4 2025 and bottomed at $93.2 million in Q1 2024.
  • Average Common Equity over 5 years is $106.1 million, with a median of $102.8 million recorded in 2022.
  • Peak YoY movement for Common Equity: decreased 14.33% in 2022, then rose 24.0% in 2025.
  • A 5-year view of Common Equity shows it stood at $112.6 million in 2021, then decreased by 10.26% to $101.0 million in 2022, then dropped by 5.28% to $95.7 million in 2023, then increased by 8.62% to $103.9 million in 2024, then grew by 24.0% to $128.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were $128.8 million in Q4 2025, $120.8 million in Q3 2025, and $112.3 million in Q2 2025.